Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-01-21 @ 6:13 AM
Study NCT ID:
NCT00619957
Status:
COMPLETED
Last Update Posted:
2011-10-28
First Post:
2008-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
Sponsor:
Warner Chilcott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-11
First Submit QC Date:
None
Study First Post Date:
2008-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-05-23
Results First Submit QC Date:
None
Results First Post Date:
2011-10-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-09-20
Last Update Post Date:
2011-10-28
Last Update Post Date Type:
ESTIMATED